Example: Heart Attack
Search clinical trials for: Ethyl 2-cyanoacrylate
Total 0 results
We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
Medical Conditions
- COVID-19
- Active Learning Methods and Life-skills Education
- Advanced Cancer Entities
- Ann Arbor Stage I Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue
- Anticholinergics
- Ataxia-telangiectasia
- CABGs
- Epstein-Barr Virus Infection
- Evidence of Cholecystectomy
- Pain Relief to the Patient Following Abdominal Surgeries
- Penis Cancer
- Postoperative Pain After Breast Reconstruction With Abdominal Flap
- Re-intubation
- Skin Viscoelasticity
- View Full List
Sponsors and Collaborators
- Charsire Biotechnology Corp.
- Cowan Foundation
- Hospital Departamental de Villavicencio
- Institut Hospitalo-Universitaire Méditerranée Infection
- MAPI
- Mark Stein
- Neovia Oncology Ltd.
- North Eastern Weight Loss Surgery
- Pinyo Rattanaumpawan
- SGS S.A.
- Second People's Hospital of Foshan City
- Statim Technologies, LLC
- The Coordination Unit in the Orkdal region (SIO)
- View Full List
Drug Interventions
- (capecitabine, oxaliplatin, 5-fluorouracil)
- 5-Azacytidine (5-AZA) group 3
- Antibiotic-first therapy
- BLI1100
- Betrixaban
- Concentrated herbal extract granules TRA
- FDC of candesartan cilexetil 16 mg and HCTZ 12.5mg
- Gadofosveset trisodium (Ablavar™ )
- Mixture brachial plexus block
- Neostigmine+Glycopyrronium
- PecFent and Epistatus
- TG-2349 (400 mg) plus DAG181 (200 mg)
- balicatib (AAE581)
- View Full List
Conditions
Rare Diseases
Drug Interventions
Dietary Supplements
Sponsor/Collaborators
Locations